Correlation Between Sonnet Biotherapeutics and Verastem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Verastem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Verastem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Verastem, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Verastem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Verastem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Verastem.

Diversification Opportunities for Sonnet Biotherapeutics and Verastem

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sonnet and Verastem is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Verastem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verastem and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Verastem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verastem has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Verastem go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Verastem

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Verastem. In addition to that, Sonnet Biotherapeutics is 1.02 times more volatile than Verastem. It trades about -0.6 of its total potential returns per unit of risk. Verastem is currently generating about 0.18 per unit of volatility. If you would invest  328.00  in Verastem on August 24, 2024 and sell it today you would earn a total of  65.00  from holding Verastem or generate 19.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sonnet Biotherapeutics Holding  vs.  Verastem

 Performance 
       Timeline  
Sonnet Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Verastem 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.

Sonnet Biotherapeutics and Verastem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonnet Biotherapeutics and Verastem

The main advantage of trading using opposite Sonnet Biotherapeutics and Verastem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Verastem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verastem will offset losses from the drop in Verastem's long position.
The idea behind Sonnet Biotherapeutics Holdings and Verastem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios